...
首页> 外文期刊>Journal of drug targeting >Lipid-coated calcium phosphate nanoparticle and beyond: a versatile platform for drug delivery
【24h】

Lipid-coated calcium phosphate nanoparticle and beyond: a versatile platform for drug delivery

机译:脂质涂覆的磷酸钙纳米粒子及其超出:用于药物递送的多功能平台

获取原文
获取原文并翻译 | 示例
           

摘要

In recent years, lipid-coated calcium-phosphate (LCP) nanoparticle has been developed as a versatile platform for delivery of various therapeutics including gene, protein/peptide, chemotherapeutics and theranostic agents. The high endosomal escape, coupled with the ability to efficiently encapsulate phosphorylated drugs or prodrugs, make LCP become attractive vehicle for drug delivery. Additionally, the principle behind LCP formulation has also allowed rational design of LCP-derived nanoparticles (NPs) with other solid core or lipid membrane to overcome the various drug delivery barriers. Here, we briefly review the history of the development of LCP NPs, highlight the optimisations and modulations in the development process, and summarise the major applications of LCP NPs and LCP-derived NPs in drug delivery. ? 2017 Informa UK Limited, trading as Taylor & Francis Group.
机译:近年来,已经开发出脂质涂覆的钙磷酸钙(LCP)纳米粒子作为通用平台,用于提供各种治疗剂,包括基因,蛋白质/肽,化学治疗剂和治疗剂。 高压骨髓逸出,加上有效包封磷酸化药物或前药的能力,使LCP成为吸引药物递送的吸引力。 另外,LCP配方背后的原理也允许用其他固体核或脂质膜的LCP衍生的纳米颗粒(NPS)的合理设计,以克服各种药物输送屏障。 在这里,我们简要介绍了LCP NPS发展的历史,突出了开发过程中的优化和调制,并总结了LCP NPS和LCP衍生NPS在药物递送中的主要应用。 还 2017年Informa UK Limited,贸易为泰勒&弗朗西斯集团。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号